Related Experiment Video
Updated: May 4, 2026

07:59
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
6.2K
Hepatobiliary organoid research: the progress and applications
Rui-Qi Zou1,2, Yu-Shi Dai1,2, Fei Liu1,2
1Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in Pharmacology
|February 26, 2025
Summary
Organoid culture technology offers advanced "in vitro micro-organs" for studying liver and biliary diseases. These models show promise for drug development and regenerative medicine, though further refinement is needed.
Area of Science:
- Life Sciences
- Biotechnology
- Organoid Technology
Background:
- Organoid culture technology enables the creation of "in vitro micro-organs" that mimic native tissue structure and function.
- Organoids serve as crucial preclinical models for disease research and therapeutic development.
- Hepatobiliary diseases remain a significant challenge, necessitating improved research models and treatment strategies.
Purpose of the Study:
- To introduce organoid definition and advantages.
- To describe the development and advances in hepatobiliary organoids research.
- To highlight the application of hepatobiliary organoids in disease research, drug discovery, and regenerative medicine.
Main Methods:
- Review of organoid culture technology.
- Focus on hepatobiliary organoids.
- Discussion of applications in liver and biliary tract diseases.
Main Results:
- Organoids faithfully recapitulate organogenesis, structure, function, and pathology.
- Hepatobiliary organoids are valuable for studying benign and malignant diseases.
- Organoid technology provides a new avenue for addressing challenges in hepatobiliary research.
Conclusions:
- Organoid culture technology is a promising tool for advancing hepatobiliary disease research and treatment.
- Despite current limitations, organoids offer significant potential for drug research and regenerative medicine.
- Integration with technologies like CRISPR-HOT and organ-on-a-chip may enhance future organoid development.

